Interest of S100B protein blood level determination for the management of patients with minor head trauma;Intérêt du dosage sérique de la protéine S100B dans la prise en charge du patient aprés traumatisme crânien léger

Annales de Biologie Clinique

Volumn 67, Issue 4, 2009, Pages 425-431

  Bouvier, D ^a   Oddoze, C ^b   Ben Haim, D ^b   Moustafa, F ^a   Legrand, A ^c   Alazia, M ^b   Jehle, E ^a   Schmidt, J ^a   Sapin, V ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Minor head injury; Pranial computed tomography; S100B protein

Indexed keywords

BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADULT; ARTICLE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FRANCE; HEAD INJURY; HUMAN; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL;

ADULT; BIOLOGICAL MARKERS; CRANIOCEREBRAL TRAUMA; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PATIENT SELECTION; PROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 73949153044     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2009.0347     Document Type: Article

References (20)

1. Tiret L, Hausherr E, Thicoïpé M, Garros B, Maurette P, Castel JP, et al. The epidemiology of head trauma in Aquitaine (France), 1986: a community-based study of hospital admissions and deaths. Int J Epidemiol 1990; 19:133-40.
2. Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet 2001; 357:1391.
3. e Conférence de Consensus en Réanimation et Médecine d'urgence. Radiographies thoraciques et radiographies du crâne en urgence. 4 mai 1990.
4. Masters SJ, Mc Clean PM, Arcarese JS, Brown RF, Campbell JA, Freed HA, et al. Skull X Ray examinations after head trauma. Recommendations by a multidisciplinary panel and validation study. N Engl J Med 1987; 316:84-91.
5. Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, et al. Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury. A prospective multicenter study. Shock 2006; 25:446-53.
6. Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, et al. S100B serum level predicts computed tomography findings after minor head injury. J Trauma 2007; 62:1452-6.
7. Poli-de Figueiredo LF, Biberhaler P, Simao Filho C, Hauser C, Mutschler W, Jochum M. Measurement of S-100B for risk classification of victims sustaining minor head injury - First pilot study in Brazil. Clinics 2006; 61:41-6.
8. Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, Gippner-Steppert C, et al. Evaluation of S-100B as a specific marker for neuronal damage due to minor head injury. World J Surg 2001; 25:93-7.
9. Beaudeux JL, Dequen L, Foglietti MJ. La protéine S-100beta: un nouveau marqueur biologique de pathologie cérébrale. Ann Biol Clin (Paris) 1999; 57:261-72.
10. Beaudeux JL, Soler C, Foglietti MJ. Physiopathologie de la protéine S-100B: intérêt de son dosage en biologie clinique. Immunoanal Biol Spec 2002; 17:280-6.
11. Beaudeux JL, Roche S, Puyssabet L, Foglietti MJ. Physiologie de la protéine S100B et apport de son dosage dans les pathologies neurologiques. Immunoanal Biol Spéc 2001; 16:141-8.
12. Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neurpsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 2001; 70:95-100.
13. Mussack T, Biberthaler P, Wiedemann E, Kanz KG, Englert A, Gippner-Stepperet C, et al. S-100b as a screening marker of the severity of minor head trauma (MHT) - a pilot study. Acta Neurochir Suppl 2000; 76:393-6.
14. Hallèn M, Carlhed R, Karlsson M, Hallgren T, Bergenheim M. A comparison of two different assays for determining S-100B in serum and urine. Clin Chem Lab Med 2008; 46:1025-9.
15. Anderson RE, Hansson LO, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 2001; 71:1512-7.
16. Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F. Rapid elimination of protein S-100B from serum after minor head trauma. J Neurotrauma 2006; 23:149-55.
17. Springborg JB, Unden J, Ingebrigsten T, Romner B. Brain injury marker S100B can reduce the use of computer tomography in minor head injuries-secondary publication. Ugeskr Laeger 2009; 171:978-81.
18. Unden J, Ingebrigsten T, Romner B. Management of minor head injuries with the help of a blood test. S100B analysis can reduce the number of CT examinations and patient admissions. Lakartidningen 2008; 105:1846-8.
19. Beaudeux JL. La protéine S100B: premier marqueur biologique pour le diagnostic du traumatisme crânien mineur ou modéré. Ann Pharm Fr 2009:187-94.
20. Otto M, Holthussen S, Bahn E, Söhnchen N, Wiltfang J, Geese R, et al. Boxing and running lead to rise in serum levels of S-100B protein. Int J Sports Med 2000:551-5.